Vogenx, Inc. (VOGX)
18.72
+0.49
(+2.69%)
USD |
NASDAQ |
Nov 06, 10:21
Vogenx Net Income (Quarterly) : -0.3844M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3844M |
| March 31, 2026 | -0.4755M |
| Date | Value |
|---|---|
| June 30, 2025 | -0.2948M |
| March 31, 2025 | -0.3566M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| IGC Pharma, Inc. | -2.936M |
| Cocrystal Pharma, Inc. | -3.164M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Arvinas, Inc. | -53.90M |
| Fulcrum Therapeutics, Inc. | -26.18M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.3844M |
| EPS Diluted (Quarterly) | -0.0259 |
| Enterprise Value | 271.48M |
| Earnings Yield | -0.54% |
| Normalized Earnings Yield | -0.5395 |